PCI Biotech Holding ASA
OSE:PCIB
PCI Biotech Holding ASA
OSE:PCIB
Price:
0.1935
NOK
4.59%
Market Closed
Market Cap:
kr7.2m
Relative Value
The Relative Value of one
PCIB
stock under the Base Case scenario is
hidden
NOK.
Compared to the current market price of 0.1935 NOK,
PCI Biotech Holding ASA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PCIB Relative Value
HIDDEN
Multiples Across Competitors
PCIB Competitors Multiples
PCI Biotech Holding ASA Competitors
PCI Biotech Holding ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
|
PCI Biotech Holding ASA
OSE:PCIB
|
7.2m NOK | 1.5 | -0.4 | 0.3 | 0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
391.4B USD | 6.5 | 166.4 | 16.2 | 22.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.4B USD | 5.5 | 26.1 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189.1B USD | 6.4 | 23.1 | 15.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.9B USD | 10.2 | 32.5 | 23.9 | 24.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.1 | 15.4 | 17.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.4B AUD | 3.9 | 20.2 | 13.5 | 16.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR | 14.1 | 33 | 56.3 | 57.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
